Jefferies is testing investor appetite for about $5 billion of debt financing to back Carl Icahn in a potential rival bid for Caesars Entertainment, according to people familiar with the matter.
3:01 PMBloomberg Markets5 stories from 3 sources
Strategic buyers put capital behind growth and distribution
Day’s Recap
Supporting Articles
Vertex agreed to buy Crinetics Pharmaceuticals for $10 billion in cash, pushing Crinetics shares sharply higher. Separately, Fiserv shares rose on reports that major banks are discussing a potential acquisition of a Fiserv-owned payments network.
11:03 AMBloomberg MarketsVertex Pharmaceuticals plans to acquire Crinetics Pharmaceuticals for about $10 billion, adding Crinetics' lead drug for a rare endocrine disorder to its pipeline.
9:14 AMStat NewsAdnoc Distribution agreed to buy Shell's fuel station network in South Africa in a deal valued at about $1 billion. The company says the acquisition fits its strategy to expand its retail footprint in key growth markets.
2:16 AMBloomberg MarketsAdnoc agreed to buy Shell’s South African downstream fuels business for about $1 billion, including roughly 580 service stations and related distribution assets. The deal extends Adnoc’s push to acquire overseas retail and logistics platforms.
12:15 AMFinancial Times3:01 PMBloomberg Markets
Jefferies Shops $5 Billion Debt for Icahn’s Possible Caesars Bid
Summary
Jefferies is testing investor appetite for about $5 billion of debt financing to back Carl Icahn in a potential rival bid for Caesars Entertainment, according to people familiar with the matter.
Why it matters
Committed debt changes a rumor into a bankable threat, raising the odds of a bidding war and pushing up the cost of capital and the clearing price for Caesars.
11:03 AMBloomberg Markets
SpaceX Joins Nasdaq 100; Crinetics Pharmaceuticals Soars on Buyout | Stock Movers
Summary
Vertex agreed to buy Crinetics Pharmaceuticals for $10 billion in cash, pushing Crinetics shares sharply higher. Separately, Fiserv shares rose on reports that major banks are discussing a potential acquisition of a Fiserv-owned payments network.
Why it matters
These moves point to a more active M&A tape where cash-rich strategics and incumbents use acquisitions to buy growth and control distribution in healthcare and payments.
9:14 AMStat News
STAT+: Pharmalittle: We’re reading about a $10 billion Vertex deal, the pace of FDA drug approvals, and more
Summary
Vertex Pharmaceuticals plans to acquire Crinetics Pharmaceuticals for about $10 billion, adding Crinetics' lead drug for a rare endocrine disorder to its pipeline.
Why it matters
A $10B biotech buy signals renewed willingness to pay for pipeline certainty and can reset valuations across rare-disease M&A.
2:16 AMBloomberg Markets
Adnoc to Buy Shell's South African Fuel Stations
Summary
Adnoc Distribution agreed to buy Shell's fuel station network in South Africa in a deal valued at about $1 billion. The company says the acquisition fits its strategy to expand its retail footprint in key growth markets.
Why it matters
It signals faster consolidation and new Gulf capital in African fuel retail, reshaping competition and investment in South Africa's downstream market.
12:15 AMFinancial Times
UAE’s Adnoc strikes $1bn deal for Shell’s South African fuels business
Summary
Adnoc agreed to buy Shell’s South African downstream fuels business for about $1 billion, including roughly 580 service stations and related distribution assets. The deal extends Adnoc’s push to acquire overseas retail and logistics platforms.
Why it matters
This deal signals faster consolidation in global fuel retail as national oil companies buy scale while majors keep exiting non-core downstream assets.
Make it yours
Build Your First Pass.
Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!